wegovy
novo nordisk a/s - semaglútíð - obesity; overweight - Ónæmiskerfi, þó ekki mataræði - wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial body mass index (bmi) of- ≥30 kg/m² (obesity), or- ≥27 kg/m² to.
roctavian
biomarin international limited - valoctocogene roxaparvovec - antihemorrhagics - treatment of severe haemophilia a (congenital factor viii deficiency) in adult patients without a history of factor viii inhibitors and without detectable antibodies to adeno-associated virus serotype 5 (aav5).
amvuttra
alnylam netherlands b.v. - vutrisiran sodium - amyloid neuropathies, familial - Önnur lyf í taugakerfinu - treatment of hereditary transthyretin-mediated amyloidosis (hattr amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.
plerixafor accord
accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - Ónæmisörvandi, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.
visanne tafla 2 mg
bayer ab* - dienogestum inn - tafla - 2 mg
rabeprazol medical valley magasýruþolin tafla 20 mg
medical valley invest ab - rabeprazolum natríum - magasýruþolin tafla - 20 mg
ivermectin medical valley tafla 3 mg
medical valley invest ab - ivermectinum inn - tafla - 3 mg
clindamycin eql pharma hart hylki 150 mg
eql pharma ab - clindamycinum hýdróklóríð - hart hylki - 150 mg
clindamycin eql pharma hart hylki 300 mg
eql pharma ab - clindamycinum hýdróklóríð - hart hylki - 300 mg
epirubicin actavis stungulyf, lausn 2 mg/ml
actavis group ptc ehf. - epirubicinum hýdróklóríð - stungulyf, lausn - 2 mg/ml